Eleos Health turns behavioral health conversations into documentation and intelligence that drives better care. Using proprietary, voice-based Natural Language Understanding (NLU) technology built by clinical experts to accurately interpret, analyze and document behavioral health conversations, Eleos reduces documentation work by over 50% while unlocking objective insights into evidence-based care and the therapeutic alliance through augmented intelligence.
Leadership teams can scale supervision and training while gaining unprecedented visibility into staff activity, caseloads and performance as well as population health. Eleos is the only technology of its kind that embeds seamlessly into electronic health records (EHRs), telehealth tools and existing provider workflows. With Eleos CareOps Automation, behavioral health providers and health plans are setting a new standard for care.
Woebot Health is the mental health ally for people and businesses that is answering the skyrocketing need for mental health care by breaking down the systemic constraints that block equal access to it. Our relational agent, Woebot, is at the heart of an AI-powered platform that can tailor products for specific intended uses and patient populations. It’s also the foundation of our solutions, which are based on Cognitive Behavioral Therapy (CBT) and include support tools for adults, adolescents and new mothers. We work directly with virtual primary care companies, payers and IDNs to put safe, scalable and validated mental health solutions directly in the hands of those who need them.
How are early adopters from provider, payer, academic, regulatory and pharma incorporating generative AI technologies into their workflows? At the Generative AI for Healthcare Summit, meet the key generative AI innovators who are already reimagining their system and adminsitrative processes and optimizing the path to better, more personalized patient care.
With an audience capped at 100, forge meaningful connections with a diverse range of senior-level healthcare executives from the likes of Point32 Health, Boston Medical Center, Mount Sinai, Sanofi and more. Join facilitated networking sessions designed to encourage cross-industry collaboration as we all tackle the new generative AI opportunity together. Leave with high value connections that extend beyond the Summit!
How can generative AI reduce administrative burdens and staff burnout? How can organizations ethically and responsibly deploy generative AI, and boost interoperability when working with new systems? Through extensive research, this Summit addresses the industry’s burning questions, and through panels and open discussions, affords you the chance to bring your organization’s greatest challenges to the table.
“This conference is important because it brings together the relevant stakeholders in this important field, which could transform the field of biomedicine.”
“As generative AI has the power to be transformative in healthcare, shared perspectives will be key to understanding the nuances of this innovation to ensure thoughtful deployment.”
“Generative AI has the potential to transform healthcare by enabling more personalized and accurate diagnoses, more efficient drug discovery, and more effective treatment plans. As the technology continues to improve and become more widely adopted, it could become a new paradigm for healthcare applications.”
“As someone working in healthcare workforce intelligence and planning, the summit will be an excellent opportunity to explore the latest development and applications of AI in healthcare. With so much expertise coming together to share their insights and experiences, this will be a valuable event.”
“It is incredibly important that we think carefully about how Generative AI should be integrated into care. Hearing a wide variety of viewpoints will be key to doing so.”
Expert Speaker Faculty
David is the Chief Executive Officer of Cerebral, a tele-health company that has provided high quality mental healthcare to more than 750,000 patients across all 50 states, and has raised over $450 million in venture funding. He serves as the Director of Massachusetts General Hospital Psychiatry’s Innovation Council, and he is a member of the Forbes Business Council. Previously, David was President, Co-founder and Chief Medical Officer of Valera Health, a telehealth company that reduced unnecessary hospitalizations for patients with serious mental illness. David is on faculty at Harvard Medical School, where he has conducted research on how digital technologies can help better predict and prevent suicidal behaviors. He has been named ‘Top 10 under 35 for Healthcare’ by LinkedIn, as well as a ‘Top 50 Healthcare Technology CEO for 2023’ by Healthcare Technology Report. David graduated from Harvard College with a degree in neurobiology, and earned his MD MBA from Harvard Medical School and Harvard Business School. His writings have appeared in the New England Journal of Medicine, Forbes, and Stat.
Dr. Girish N. Nadkarni is the Fishberg Professor in Medicine at the Icahn School of Medicine at Mount Sinai. He is also the Chief of the Division of Data Driven and Digital Medicine (D3M) and the Director of the Charles Bronfman Institute of Personalized Medicine. He received training in Mathematics before completing his medical degree at one of the top-ranked medical colleges in India. He then received a Master’s in Public Health at the Johns Hopkins Bloomberg School of Public Health in Baltimore, MD, and then was a Research Associate at the Johns Hopkins Medical Institute. Dr. Nadkarni completed his residency in Internal Medicine and a clinical fellowship in Nephrology at the Icahn School of Medicine at Mount Sinai. He then completed a research fellowship in Personalized Medicine at the Charles Bronfman Institute of Personalized Medicine. Dr. Nadkarni has authored over 300 peer-reviewed scientific publications including ones in the New England Journal of Medicine, Journal of American Medical Association, Annals of Internal Medicine, The Lancet and Nature Medicine. He has received many awards including the best outgoing senior resident award, Dr. Harold and Golden Lamport research award, the ANIO rising star award and the Deal of the Year award at Sinai Innovations. He is the principal investigator for several NIH funded grants. Dr. Nadkarni is also the scientific co-founder of several investor-backed companies, two of which are publicly traded.
Shahidul Mannan is the Chief Data Officer at Bon Secours Mercy Health, where he is leading all enterprise data platform, governance, products innovation and commercialization moving forward with BSMH vision and strategy for data driven digital transformation. Most recently he was Head of Data Engineering and Innovation at Mass General Brigham where he was leading the next generation data analytics architecture and platforms for MGB (formerly Partner’s Healthcare) digitization and Analytics Innovation. Shahidul was also at Dell EMC as Global Head of Big data and Analytics – leading all data assets and building next generation Data Lake and AI driven Analytics across enterprise, and at Altisource, where he served as Vice President of Technology, Chief Data Officer – responsible for all data management, big data, business intelligence and advanced analytics, developing Fintech analytics products and services.
Mike Harmer is the Vice President of Workforce Intelligence, Planning, and Talent Intermountain Health, with responsibility for workforce planning, analytics, automation, talent acquisition, future workforce and related hr strategy development. He has worked in various roles across Intermountain covering Analytics, IT, Transformation, and HR including HRIS and HR Analytics.
Mike is involved in various external endeavors including the Board of Directors for Alpine Testing Solutions and in research at ThinkTroop. He is a frequent speaker at industry conferences, holds a master’s degree in Public Administration and is fluent in German. When he’s not analyzing things, he enjoys sailing, canyoneering, and backpacking with his kids.
Dr. Katherine Gergen Barnett is the Vice Chair of Primary Care Innovation and Transformation in the Department of Family Medicine at Boston Medical Center (BMC), a Clinical Associate Professor at Boston University Chobanian & Avedisian School of Medicine, an Associate at Harvard’s Center for Primary Care, and a Health Innovators Fellow at the Aspen Institute, a highly competitive fellowship that catalyzes leaders to improve US health care.
Prior to joining BMC in 2009, Dr. Gergen Barnett attended Yale University School of Medicine, worked at the National Institutes of Health, and completed a fellowship studying a model of group prenatal care for women in low-income communities. At BMC, she has served in multiple leadership roles including as a chief resident, Director of Integrative Medicine, Medical
Director, Residency Director, and Vice Chair. Her primary clinical interests are behavioral health, preventive medicine, nutrition, trauma informed care, gender affirming care, women’s health,
reproductive care, mindfulness-based stress reduction, and group medical care.
Dr. Gergen Barnett’s research career has been focused on innovative models of care to address chronic medical conditions, physician burnout, and engaging community partners in creating feasible solutions to increase health and wellness and to address medical distrust in traditionally marginalized communities. Dr. Gergen Barnett brings her training and passion for community engaged research to her role as PI in a clinical trial evaluating the safety and efficacy of Paxlovid, an antiviral, in treating high risk children infected with COVID-19.
Finally, Dr. Gergen Barnett is involved in local and state health policy addressing health inequities, national policy addressing primary care delivery, and is a regular contributor to The Boston Globe, Boston Public Radio, and multiple television outlets.
Dr. Lin is the Founder and Executive Director of the Stanford Healthcare AI Applied Research Team (HEA3RT). He is an expert clinician, educator, researcher, and health system leader in the specialty of family medicine. Dr. Lin earned his MD from Stanford University School of Medicine and completed his training at Stanford’s family medicine residency program. He has received numerous national awards and is recognized among the top family physicians in the United States.
Dr. Lin is the Chief of General Primary Care and the Head of Technology Innovation for the Division of Primary Care and Population Health. His focus is on the intersection of health services innovation, digital health and emerging technologies – specifically artificial intelligence and machine learning in healthcare. Dr. Lin is currently the James C. Puffer/American Board of Family Medicine Fellow with the National Academy of Medicine. He is the author of over 400 scholarly works and conference presentations.
Samuel “Sandy”; Aronson is the Executive Director of IT for Mass General Brigham Personalized Medicine, an Associate Director of Mass General Brigham Research Information Science and Computing as well as the Senior Director of IT for our Accelerator for Clinical Transformation. His teams develop and deploy technology to improve clinical processes in clinical genetics, remote health and decentralized clinical trials. In clinical genetics, the team has built infrastructre that supports the evolution and practice of genetic based personalized medicine in both patient facing and laboratory settings. This system ecosystem enables a continuous learning process that harnesses clinical testing flows to advance knowledge surrounding genetic variation. The infrastructure includes the GeneInsight Suite of applications that were registered as a medical device and distributed. The team is now working to deepen support for whole genome sequence management and interpretation.
The team has also deployed a platform that enables remote patient management by task shifted workforces using omnichannel communication. These capabilities have been used to equitably manage large patient populations. The platform is also currently supporting multiple decentralized clinical trials.
Prior to this position, Mr. Aronson was an IT consultant to the biotechnology industry working for Tribiosys. Mr. Aronson also held several positions with Sapient Corporation, was a Strategic Consultant for Monitor Company and founded LearningAction, a web-based training company now part of Best Software. Mr. Aronson holds a Masters in Organizational Behavior and a Bachelors in Computer Science from Stanford University. He also holds a Masters focused in Biology from Harvard Extension School.
Kathleen has spent 11 years in software, starting her career as a founding team member at Cambridge based start up, Grapevine. Her experience extends from helping enterprise organizations with digital transformation through customer data, analytics, and overall digital strategy, into her current role of partnering with Behavioral Health Organizations to transform their overall operations to retain staff and improve outcomes for clients.
Jana Gunn is a seasoned analytics and data science professional with over 20 years of experience delivering actionable insights that drive impactful decision-making. She holds a Bachelor of Science in Business Administration from the University of Illinois at Urbana-Champaign and a Master of Science in Predictive Analytics (Data Science) from Northwestern University.
Jana’s career journey has been marked by continuous growth and leadership roles with companies including Walgreens, Optum, UnitedHealth Group and most recently as Sr. Director of Advanced Analytics and Data Science at Blue Cross Blue Shield of Minnesota. She oversees multiple teams including Data Science, Risk Adjustment and Quality, Population Health and Trend Analytics, ensuring the delivery of high-quality data-driven insights.
One of Jana’s standout strengths lies in her ability to address social determinants of health (SDoH) for populations with unmet social needs. Her analytical solutions have made a significant impact on improving healthcare outcomes. In addition, Jana has demonstrated a commitment to responsible AI, specializing in fairness testing, explainability, and ethical considerations. Her contributions extend beyond her organizations, as she has presented her work at prestigious events like the Grace Hopper Celebration.
Personally, Jana has a passion for teaching and serving others. She has taught courses on Healthcare Analytics and mentored aspiring data scientists as a member of Women in Analytics and Data Science. She also volunteers at Feed My Starving Children, packing meals for children in impoverished countries.
Dr. Glass received her BS in Neuroscience with Departmental Honors from the University of California at Los Angeles (UCLA) in 1997, before earning her MS from Baylor College of Medicine and MD from the University of Texas Medical Branch, Magna Cum Laude in 2007. Dr. Glass initially trained as a vascular surgeon with a focus on endovascular/interventional procedures through the Integrated Vascular Surgery Program at the University of Rochester Medical Center. As a recipient of the NIH National Lung Blood Institute T32 Ruth Kirschstein National Service Research Award, she completed a Ph.D with a concentration in Genomics and Epigenetics in 2014.
Dr. Glass completed residency in Anatomic Pathology at the Brigham and Women’s Hospital/Harvard Medical School in 2016 followed by fellowships in Cardiothoracic Pathology also at Brigham and Women’s Hospital and Pulmonary/Transplant Pathology at the University of Texas Southwestern Medical Center. As a thoracic pathologist, Dr. Glass also has a special interest in identifying new epigenetic biomarkers that may predict response or resistance to conventional, targeted and immune therapy using computational techniques. She works closely with the Duke Thoracic Oncology Group, DCI Center for Cancer Immunotherapy, Duke Division of Cardiovascular Medicine and Cardiothoracic Surgery.
Dr. Glass is the recipient of the Society of Cardiovascular Pathology (SCVP) Young Investigator’s Award, the William von Liebig Vascular Biology Research Fellowship at the Harvard Institutes of Medicine, the Duke Pathology Salvatore V. Pizzo Faculty Research Mentor Award, the Duke Department of Pathology Early Career Research Achievement Award and is author of over 80 publications (including book chapters in the recent W.H.O. Classification Tumours of the Lung, Pleura, Thymus and Heart) and 40 national presentations in cardiovascular disease, thoracic malignancies, surgery and machine learning. Dr. Glass is also an NIH-funded Investigator (U54, SBIR).
In addition to her clinical and research activities, Dr. Glass serves on the Executive/National Committees for the Society of Cardiovascular Pathology, College of American Pathology Artificial Intelligence Committee and the Duke School of Medicine Executive Admissions Committee.
Dr. Patel is a physician engineer, informatician, active teacher and researcher. He has a special interest in machine and deep learning, mathematical modeling of biological processes, informatics and 3D printing. He is Chair of Department of Radiology, Medical Director for 3D Imaging and Printing Laboratory for Geisinger and leads the informatics efforts in Radiology at Geisinger. Dr. Patel has published 90 research articles, review articles, textbook chapters and abstracts and has given several invited lectures at regional, national and international conferences. Dr. Patel is an electrical engineer and clinically an Interventional Radiologist. His clinical research interests include dialysis access management and interventional oncology. He led Radiology and Interventional Radiology simulation program at Penn Medicine Clinical Simulation Center. For eight years, he has been in various leadership positions at Geisinger. He is boarded in Diagnostic Radiology, Interventional Radiology and Clinical Informatics and is a Fellow of the Society of Interventional Radiology.
Sumeet S. Chugh MD, is the Price Endowed Professor of Cardiac Electrophysiology, Associate Director of the Heart Institute, Medical Director of the Heart Rhythm Center and Director of the Division of Artificial Intelligence in Medicine at Cedars-Sinai, Los Angeles. He is also Professor of Medicine-in-Residence at the David Geffen School of Medicine at UCLA. His scientific career has been dedicated to understanding the etiology and mechanisms of sudden cardiac death in the community. He is the current President of the Association of University Cardiologists and current President of the Cardiac Electrophysiology Society. He is an elected member of the American Society for Clinical Investigation. Dr. Chugh has led an independent and continuously funded translational research program since 2001 and has published over 225 peer-reviewed scientific papers. He is a frequent lecturer on sudden death and arrhythmia-related topics and has accepted more than 350 national, international and regional invited speaking engagements.
Jason Parent is the Director of Clinical Innovation for Point32Health, the parent company of Tufts Health Plan and Harvard Pilgrim Health Care. Jason’s primary focus within Point32Health is catalyzing innovation within our healthcare community to achieve healthier living for everyone. He first joined Harvard Pilgrim in 2014, leading the medical informatics initiatives on clinical program evaluation. Before joining Harvard Pilgrim, Jason was a valued member of the clinical operations and information technology team at Mass General Brigham, where he focused on developing evidence-based solutions to improve patient outcomes and quality. In addition to his current role, Jason is also a Family Nurse Practitioner, using his experience and perspective in treating patients to guide everyday decisions.
We’re pleased to be coming together in Cambridge, MA at The Royal Sonesta Boston.
We have a discounted booking link available for attendees of the Generative AI for Healthcare Summit available until October 23rd. Click here to book a room.
Full Venue Address
The Royal Sonesta Boston
40 Edwin H Land Blvd, Cambridge, MA 02142, United States
Main room: Charles Suite
Please contact firstname.lastname@example.org if you have any questions about the venue or accommodation.
Partner with Us
Bringing together senior-level executives from across the industry, the Generative AI for Healthcare Summit promises an unrivalled networking and learning opportunity for everyone working in this space.
This forum provides a rare opportunity to showcase your offering to a dedicated, world-class audience. Spaces are limited this year!
Please contact our Commercial Manager Elliott (email@example.com), to discuss opportunities for involvement.